BENZANNULATION APPROACH TO BIARYL ETHERS
二芳基醚的苯环化方法
基本信息
- 批准号:6386476
- 负责人:
- 金额:$ 17.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-05-01 至 2003-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Our long-range research objective is to demonstrate the effective use of a benzannulation reaction in the synthesis of complex natural products containing biaryl ethers as an important structural feature. The relevance of biaryl ethers to health is illustrated by vancomycin which, in the clinic, is used to treat methicillin-resistant Staphylococcus aureus and other gram-positive bacteria. The emerging bacterial strains resistant to vancomycin justifies the search for new efficient synthetic methodologies toward the biaryl ether moiety of these molecules. Oligomeric ellagitannins, such as sanguiin H-6 which demonstrates an in vitro potency 100-200 times the clinically useful DNA topoisomerase II inhibitor etoposide (VP-16), are characterized by an digalloyl biaryl ether linker between the monomeric units. Our research will explore the utility of a [3+2+1] cycloaddition reaction (the Dotz reaction) to construct an aromatic ring in the syntheses of functionalized biaryl ethers. Key to this methodology is the reaction of O-aryl- Fischer chromium carbene complexes with alkynes to give diversely substituted biaryl ethers. The traditional Dotz reaction uses O-alkyl- unsaturated carbene complexes to form alkyl-aryl ethers. The use of O-aryl-unsaturated carbenes will lead to biaryl ethers which constitutes an unprecedented application of the Dotz reaction in organic synthesis. This approach is particularly advantageous due to the mild neutral reaction conditions required for cyclization and the availability of highly substituted electron-rich aromatic systems that are currently difficult to obtain using existing technology for the synthesis biaryl ethers.
我们的长期研究目标是证明有效地使用benzannulation反应在合成复杂的天然产物含有联芳醚作为一个重要的结构特征。联芳醚与健康的相关性由万古霉素说明,万古霉素在临床上用于治疗耐甲氧西林金黄色葡萄球菌和其他革兰氏阳性菌。 新出现的耐万古霉素的细菌菌株证明了寻找新的有效的合成方法对这些分子的联芳醚部分。低聚鞣花单宁,如血根素H-6,其体外效力是临床上有用的DNA拓扑异构酶II抑制剂依托泊苷(VP-16)的100-200倍,其特征在于单体单元之间的二别戊酰基联芳基醚接头。我们的研究将探索[3+2+1]环加成反应(Dotz反应)在合成功能化联芳醚中构建芳环的实用性。该方法的关键是O-芳基- Fischer铬卡宾配合物与炔反应得到二取代的联芳醚。 传统的Dotz反应使用O-烷基-不饱和卡宾络合物来形成烷基-芳基醚。O-芳基不饱和卡宾的使用将导致联芳醚,这构成了Dotz反应在有机合成中前所未有的应用。 由于环化所需的温和中性反应条件以及高度取代的富电子芳香族体系的可用性,这种方法特别有利,而目前使用现有的联芳醚合成技术难以获得这些体系。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Diaryl ethers using Fischer chromium carbene mediated benzannulation.
使用费歇尔铬卡宾介导的苯并环化反应生成二芳基醚。
- DOI:10.1021/ol990949u
- 发表时间:1999
- 期刊:
- 影响因子:5.2
- 作者:Pulley,SR;Sen,S;Vorogushin,A;Swanson,E
- 通讯作者:Swanson,E
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL HARMATA其他文献
MICHAEL HARMATA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL HARMATA', 18)}}的其他基金
Pseudopteroxazole and Related Antitubercular Agents
拟蝶恶唑及相关抗结核药
- 批准号:
6863274 - 财政年份:2004
- 资助金额:
$ 17.18万 - 项目类别:
Pseudopteroxazole and Related Antitubercular Agents
拟蝶恶唑及相关抗结核药
- 批准号:
7151457 - 财政年份:2004
- 资助金额:
$ 17.18万 - 项目类别:
Pseudopteroxazole and Related Antitubercular Agents
拟蝶恶唑及相关抗结核药
- 批准号:
6986743 - 财政年份:2004
- 资助金额:
$ 17.18万 - 项目类别:
相似国自然基金
氮杂环卡宾(N-Heterocyclic Carbene, NHC)催化下联烯酸酯参与的串联环化
- 批准号:21871113
- 批准年份:2018
- 资助金额:63.0 万元
- 项目类别:面上项目
相似海外基金
RUI: Mechanisms of C-F and S-F Bond Activation and Cross-coupling with Bidentate N-heterocyclic Carbene Nickel Catalysts
RUI:双齿N-杂环卡宾镍催化剂的C-F和S-F键活化及交叉偶联机理
- 批准号:
2350537 - 财政年份:2024
- 资助金额:
$ 17.18万 - 项目类别:
Standard Grant
LEAPS-MPS: Synthesis of Photoactive Manganese Complexes With Carbene Ligands
LEAPS-MPS:用卡宾配体合成光活性锰配合物
- 批准号:
2316810 - 财政年份:2023
- 资助金额:
$ 17.18万 - 项目类别:
Standard Grant
Developing Novel Triazole-Ruthenium Carbene Complexes (TA-Ru) for Challenging Olefin Metathesis Transformations
开发新型三唑-钌卡宾配合物(TA-Ru)以应对具有挑战性的烯烃复分解转化
- 批准号:
2246822 - 财政年份:2023
- 资助金额:
$ 17.18万 - 项目类别:
Continuing Grant
Development of Stable Carbene Motifs that Bring out the Characteristic Properties of Group 16 Elements and Their Application to Synthetic Chemistry
展现16族元素特性的稳定卡宾基序的开发及其在合成化学中的应用
- 批准号:
22K20541 - 财政年份:2022
- 资助金额:
$ 17.18万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Ruthenium Pincer Carbene Complexes for Reduction of Nitrous Oxide
用于还原一氧化二氮的钌钳卡宾配合物
- 批准号:
546772-2020 - 财政年份:2022
- 资助金额:
$ 17.18万 - 项目类别:
Postgraduate Scholarships - Doctoral
Unleashing Mesoionic Carbene-derived Super-reductants to Overcome the Limitations of NHC- Oxidative Organocatalysis Without a Co-Catalyst
释放介离子卡宾衍生的超级还原剂,克服无助催化剂的 NHC 氧化有机催化的局限性
- 批准号:
2153475 - 财政年份:2022
- 资助金额:
$ 17.18万 - 项目类别:
Standard Grant
Controlling Gold(I) Clustering at Pnictogen Center with N-Heterocyclic Carbene Ligands and Their Optical Properties
N-杂环卡宾配体控制金(I)在磷元素中心的团聚及其光学性质
- 批准号:
22K14691 - 财政年份:2022
- 资助金额:
$ 17.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Gold N-heterocyclic Carbene Copolymers for Durable Electrical Contact Coatings
用于耐用电接触涂层的金 N-杂环卡宾共聚物
- 批准号:
557656-2021 - 财政年份:2022
- 资助金额:
$ 17.18万 - 项目类别:
Postdoctoral Fellowships
CAS: Four-Coordinate Iron- and Cobalt-Carbene Complexes for Carbene-Transfer Catalysis
CAS:用于卡宾转移催化的四配位铁和钴卡宾配合物
- 批准号:
2154892 - 财政年份:2022
- 资助金额:
$ 17.18万 - 项目类别:
Standard Grant
Tunable Masks for Triggered N-heterocyclic Carbene Organocatalysis
用于触发 N-杂环卡宾有机催化的可调掩模
- 批准号:
2154633 - 财政年份:2022
- 资助金额:
$ 17.18万 - 项目类别:
Continuing Grant